The Journal of Maternal-Fetal & Neonatal Medicine · 2011 · 15 citations · 7 references
MedicineHematologyPediatricsHemostasisNeonatologyTransfusion MedicineBlood Component TherapyBlood Transfusion ManagementCryoprecipitate TherapyNeonatal HematologyPlasma TransfusionTransfusion SupportAcquired HypofibrinogenemiaCryoprecipitate Replacement TherapyFresh Frozen Plasma TherapyGuidelines For Cryoprecipitate UseNeonatal Cryoprecipitate UseNeonatal Exchange TransfusionNeonatal Plasma TransfusionPediatric Cryoprecipitate Use
Evidence-based indications for the use of plasma products in neonatal medicine are limited to few conditions. In the setting of inherited disorders of hemostasis, fresh frozen plasma (FFP) and cryoprecipitate should be used as replacement therapy only if the specific factor concentrate is not available. FFP is indicated to treat disseminated intravascular coagulation (DIC), liver failure, vitamin K-dependent bleeding and to reconstitute whole blood for exchange transfusion. Despite the lack of evidence, the use of cryoprecipitate to treat neonates with acquired hypofibrinogenemia during DIC or liver failure is now considered standard therapy.
7
Development of the human coagulation system in the full-term infant
M Andrew, Bosco Paes, Ruth Milner et al. · Blood · 1987 · 1.2K citations · Full text
Medicine, Pediatrics, Physiology +14
Transfusion guidelines for neonates and older children
Brenda Gibson, Audrey Todd, Irene Roberts et al. · British Journal of Haematology · 2004 · 371 citations · Full text
Medicine, Hematology, Pediatrics +17
Normal thrombin generation in neonates in spite of prolonged conventional coagulation tests
Armando Tripodi, Luca A. Ramenghi, V. Chantarangkul et al. · Haematologica · 2008 · 77 citations · Full text
Medicine, Pediatrics, Hemostasis +13